Lead sponsor
NeuroBiogen Co., Ltd
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
1
Ongoing
114
Total enrollment
8
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's DiseaseAmyloid biomarker required (PET)Ph 2Recruiting114